Walleye Capital’s DarioHealth DRIO Stock Holding History

Walleye Capital’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,482	Closed	-$3.97M	–	5070
2023 Q3	$3.97M	Buy	+60,482	New	+$4.07M	0.01%	1202

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCP

Clarity Capital Partners Newport Beach, California $280M AUM 25.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Capital's DRIO Position: Q4 2023 in Review

Walleye Capital sold out of DarioHealth (DRIO) in Q4 2023, closing a stake of 60,482 shares — an estimated $3.97M sold.

Walleye Capital first reported a position in DRIO in Q3 2023 and held it in 1 quarter. The position peaked at $3.97M in Q3 2023. 35 funds tracked by Wall St. Rank hold DRIO as of Q4 2023.

Walleye Capital reported no remaining DarioHealth position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 60,482 DarioHealth shares in Q4 2023, an estimated $3.97M.
Walleye Capital first reported a position in DarioHealth in Q3 2023 and held it in 1 quarter.
Walleye Capital's DarioHealth position peaked at $3.97M in Q3 2023.
35 funds tracked by Wall St. Rank held DarioHealth as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.